Similarly, in a different study, the percentage of CD63/EpCAM/mucin 1-triple-positive circulating EVs in BC patients was significantly higher than that of healthy controls and this was associated with an overall accuracy of 91% in BC diagnosis [167]. This evidence concerns the gene MUC1 and breast cancer.